| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |